{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:09:19Z","timestamp":1762898959323,"version":"3.40.4"},"reference-count":145,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100006280","name":"Ministerio de Ciencia y Tecnolog\u00eda","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006280","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100008530","name":"FEDER","doi-asserted-by":"crossref","award":["SAF2009-07166","SAF2011-22908","SAF2012-31831"],"award-info":[{"award-number":["SAF2009-07166","SAF2011-22908","SAF2012-31831"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.neuroscience.2013.07.026","type":"journal-article","created":{"date-parts":[[2013,7,19]],"date-time":"2013-07-19T16:02:21Z","timestamp":1374249741000},"page":"417-433","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Chronic treatment with lithium does not improve neuromuscular phenotype in a mouse model of severe spinal muscular atrophy"],"prefix":"10.1016","volume":"250","author":[{"given":"E.","family":"Dachs","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Piedrafita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Hereu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.E.","family":"Esquerda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Calder\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2013.07.026_b0005","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S1474-4422(10)70068-5","article-title":"Safety and efficacy of lithium in combination with riluzole for treatment of amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial","volume":"9","author":"Aggarwal","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0010","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1093\/hmg\/dds102","article-title":"The zinc finger protein ZPR1 is a potential modifier of spinal muscular atrophy","volume":"21","author":"Ahmad","year":"2012","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2012.05.038","article-title":"The neuroprotective effect of the GSK-3\u03b2 inhibitor and influence on the extrinsic apoptosis in the ALS transgenic mice","volume":"320","author":"Ahn","year":"2012","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0020","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/sj.ejhg.5201102","article-title":"Phenylbutyrate increases SMN expression in vitro: relevance for treatment of spinal muscular atrophy","volume":"12","author":"Andreassi","year":"2004","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0025","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1172\/JCI29562","article-title":"Trichostatin A increases SMN expression and survival in a mouse model of spinal muscular atrophy","volume":"117","author":"Avila","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0030","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1172\/JCI22922","article-title":"Lentivector-mediated SMN replacement in a mouse model of spinal muscular atrophy","volume":"114","author":"Azzouz","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0035","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1093\/hmg\/ddp076","article-title":"Delivery of bifunctional RNAs that target an intronic repressor and increase SMN levels in an animal model of spinal muscular atrophy","volume":"18","author":"Baughan","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0040","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/mt.2012.261","article-title":"Intramuscular scAAV9-SMN injection mediates widespread gene delivery to the spinal cord and decreases disease severity in SMA mice","volume":"21","author":"Benkhelifa-Ziyyat","year":"2013","journal-title":"Mol Ther"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0045","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1111\/j.1471-4159.2004.02422.x","article-title":"Glycogen synthase kinase 3: a drug target for CNS therapies","volume":"89","author":"Bhat","year":"2004","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0050","doi-asserted-by":"crossref","first-page":"11288","DOI":"10.1523\/JNEUROSCI.1764-10.2010","article-title":"In vivo NMDA receptor activation accelerates motor unit maturation, protects spinal motor neurons, and enhances SMN2 gene expression in severe spinal muscular atrophy mice","volume":"30","author":"Biondi","year":"2010","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0055","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1523\/JNEUROSCI.3237-07.2008","article-title":"Exercise-induced activation of NMDA receptor promotes motor unit development and survival in a type 2 spinal muscular atrophy model mouse","volume":"28","author":"Biondi","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0060","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1093\/hmg\/ddr067","article-title":"Increased IGF-1 in muscle modulates the phenotype of severe SMA mice","volume":"20","author":"Bosch-Marc\u00e9","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0065","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1093\/hmg\/ddq021","article-title":"Rho-kinase inactivation prolongs survival of an intermediate SMA mouse model","volume":"19","author":"Bowerman","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0070","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1741-7015-10-24","article-title":"Fasudil improves survival and promotes skeletal muscle development in a mouse model of spinal muscular atrophy","volume":"10","author":"Bowerman","year":"2012","journal-title":"BMC Med"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0075","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/sj.ejhg.5201320","article-title":"Phenylbutyrate increases SMN gene expression in spinal muscular atrophy patients","volume":"13","author":"Brahe","year":"2005","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0080","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1093\/hmg\/ddg256","article-title":"Valproic acid increases the SMN2 protein level: a well-known drug as a potential therapy for spinal muscular atrophy","volume":"12","author":"Brichta","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0085","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrn2670","article-title":"Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick?","volume":"10","author":"Burghes","year":"2009","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0090","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1093\/hmg\/ddp510","article-title":"Effects of 2,4-diaminoquinazoline derivatives on SMN expression and phenotype in a mouse model for spinal muscular atrophy","volume":"19","author":"Butchbach","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0095","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.neuroscience.2009.11.034","article-title":"Lithium prevents excitotoxic cell death of motoneurons in organotypic slice cultures of spinal cord","volume":"165","author":"Calder\u00f3","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0100","doi-asserted-by":"crossref","first-page":"3546","DOI":"10.1038\/sj.onc.1211026","article-title":"Nuclear GSK-3beta inhibits the canonical Wnt signalling pathway in a beta-catenin phosphorylation-independent manner","volume":"27","author":"Caspi","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0105","doi-asserted-by":"crossref","first-page":"8745","DOI":"10.1073\/pnas.96.15.8745","article-title":"Lithium activates the serine\/threonine kinase Akt-1 and suppresses glutamate induced inhibition of Akt-1 activity in neurons","volume":"96","author":"Chalecka-Franaszeck","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0110","doi-asserted-by":"crossref","first-page":"9808","DOI":"10.1073\/pnas.171105098","article-title":"Treatment of spinal muscular atrophy by sodium butyrate","volume":"98","author":"Chang","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0115","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1021\/cn200085z","article-title":"Identification of a maleimide-based glycogen synthase kinase-3 (GSK-3) inhibitor, BIP-135, that prolongs the median survival time of \u03947 SMA KO mouse model of spinal muscular atrophy","volume":"3","author":"Chen","year":"2012","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0120","doi-asserted-by":"crossref","first-page":"6039","DOI":"10.1074\/jbc.274.10.6039","article-title":"Long term lithium treatment suppresses p53 and Bax expression but increases Bcl-2 expression. A prominent role in neuroprotection against excitotoxicity","volume":"274","author":"Chen","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0125","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.bbrc.2012.03.006","article-title":"Activation of the Wnt\/\u03b2-catenin signaling pathway is associated with glial proliferation in the adult spinal cord of ALS transgenic mice","volume":"420","author":"Chen","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0130","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1179\/1743132812Y.0000000027","article-title":"Wnt signaling pathway is involved in the pathogenesis of amyotrophic lateral sclerosis in adult transgenic mice","volume":"34","author":"Chen","year":"2012","journal-title":"Neurol Res"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0135","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1212\/WNL.0b013e3181ed9e7c","article-title":"Lithium carbonate in amyotrophic lateral sclerosis: lack of efficacy in a dose-finding trial","volume":"75","author":"Chi\u00f2","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0140","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1034\/j.1399-5618.2002.01179.x","article-title":"Neuroprotective effects of lithium in cultured cells and animal models of diseases","volume":"4","author":"Chuang","year":"2002","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0145","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.biopsych.2007.04.008","article-title":"In search of the Holy Grail for the treatment of neurodegenerative disorders: has a simple cation been overlooked?","volume":"62","author":"Chuang","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0150","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3389\/fnmol.2011.00015","article-title":"GSK-3 as a target for lithium-induced neuroprotection against excitotoxicity in neuronal cultures and animal models of ischemic stroke","volume":"4","author":"Chuang","year":"2011","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0155","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1083\/jcb.152.5.1107","article-title":"Deletion of murine SMN exon 7 directed to skeletal muscle leads to severe muscular dystrophy","volume":"152","author":"Cifuentes-Diaz","year":"2001","journal-title":"J Cell Biol"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0160","first-page":"277","article-title":"Neuron death in vertebrate development: in vivo methods","volume":"vol. 46","author":"Clarke","year":"1995"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0165","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1523\/JNEUROSCI.4489-09.2010","article-title":"Trans-splicing-mediated improvement in a severe mouse model of spinal muscular atrophy","volume":"30","author":"Coady","year":"2010","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0170","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1093\/hmg\/6.8.1205","article-title":"The survival motor neuron protein in spinal muscular atrophy","volume":"6","author":"Coovert","year":"1997","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0175","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1172\/JCI35432","article-title":"Neural stem cell transplantation can ameliorate the phenotype of a mouse model of spinal muscular atrophy","volume":"118","author":"Corti","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0180","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1093\/brain\/awp318","article-title":"Embryonic stem cell-derived neural stem cells improve spinal muscular atrophy phenotype in mice","volume":"133","author":"Corti","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0185","doi-asserted-by":"crossref","first-page":"165ra162","DOI":"10.1126\/scitranslmed.3004108","article-title":"Genetic correction of human induced pluripotent stem cells from patients with spinal muscular atrophy","volume":"4","author":"Corti","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0190","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0896-6273(03)00195-8","article-title":"Finding the intracellular signaling pathways affected by mood disorder treatments","volume":"38","author":"Coyle","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0195","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1097\/NEN.0b013e31821cbd8b","article-title":"Defective neuromuscular junction organization and postnatal myogenesis in mice with severe spinal muscular atrophy","volume":"70","author":"Dachs","year":"2011","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0200","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1101\/gad.12.22.3499","article-title":"Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization","volume":"12","author":"Diehl","year":"1998","journal-title":"Genes Dev"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0205","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1093\/hmg\/ddq514","article-title":"Intravenous scAAV9 delivery of a codon-optimized SMN1 sequence rescues SMA mice","volume":"20","author":"Dominguez","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0210","doi-asserted-by":"crossref","first-page":"8375","DOI":"10.1523\/JNEUROSCI.2164-05.2005","article-title":"Neuroprotective mechanisms of lithium in murine human immunodeficiency virus-1 encephalitis","volume":"25","author":"Dou","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0215","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.expneurol.2008.02.025","article-title":"Identification of a battery of tests for drug candidate evaluation in the SMN\u03947 neonate model of spinal muscular atrophy","volume":"212","author":"El-Khodor","year":"2008","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0220","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1086\/338627","article-title":"Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy","volume":"70","author":"Feldk\u00f6tter","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0225","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.neuroscience.2008.06.040","article-title":"Combined lithium and valproate treatment delays disease onset, reduces neurological deficits and prolongs survival in an amyotrophic lateral sclerosis mouse model","volume":"155","author":"Feng","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0230","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.nbd.2009.10.017","article-title":"A systematic study of brainstem motor nuclei in a mouse model of ALS, the effects of lithium","volume":"37","author":"Ferrucci","year":"2010","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0235","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/brain\/113.2.433","article-title":"Acute infantile spinal muscular atrophy. Muscle apoptosis as a proposed pathogenetic mechanism","volume":"113","author":"Fidzia\u0144ska","year":"1990","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0240","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1073\/pnas.0708022105","article-title":"Lithium delays progression of amyotrophic lateral sclerosis","volume":"105","author":"Fornai","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0245","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nbt.1515","article-title":"Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes","volume":"27","author":"Foust","year":"2009","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0250","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/nbt.1610","article-title":"Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN","volume":"28","author":"Foust","year":"2010","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0255","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/0092-8674(95)90534-0","article-title":"The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase","volume":"81","author":"Franke","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0260","doi-asserted-by":"crossref","first-page":"e6489","DOI":"10.1371\/journal.pone.0006489","article-title":"No benefit from chronic lithium dosing in a sibling-matched, gender balanced, investigator-blinded trial using a standard mouse model of familial ALS","volume":"4","author":"Gill","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0265","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.bbrc.2011.11.121","article-title":"Direct central nervous system delivery provides enhanced protection following vector mediated gene replacement in a severe model of spinal muscular atrophy","volume":"417","author":"Glascock","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0270","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.1523\/JNEUROSCI.5775-11.2012","article-title":"Motor neuron rescue in spinal muscular atrophy mice demonstrates that sensory-motor defects are a consequence, no a cause, of motor neuron dysfunction","volume":"32","author":"Gogliotti","year":"2012","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0275","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s13311-011-0068-7","article-title":"Stem cell transplantation for motor neuron disease: current approaches and future perspectives","volume":"8","author":"Gowing","year":"2011","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0280","doi-asserted-by":"crossref","first-page":"51606","DOI":"10.1074\/jbc.M310722200","article-title":"Phosphorylation by glycogen synthase kinase-3 controls c-myc proteolysis and subnuclear localization","volume":"278","author":"Gregory","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0285","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/mus.10081","article-title":"Possible pathogenic role of muscle cell dysfunction in motor neuron death in spinal muscular atrophy","volume":"25","author":"Guettier-Sigrist","year":"2002","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0290","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/mus.10455","article-title":"Riluzole attenuates spinal muscular atrophy disease progression in a mouse model","volume":"28","author":"Haddad","year":"2003","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0295","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0006-2952(03)00187-4","article-title":"Search for a common mechanism of mood stabilizers","volume":"66","author":"Harwood","year":"2003","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0300","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1046\/j.0022-3042.2001.00728.x","article-title":"Lithium protection against glutamate excitotoxicity in rat cerebral cortical neurons: involvement of NMDA receptor inhibition possibly by decreasing NR2B tyrosine phosphorylation","volume":"80","author":"Hashimoto","year":"2002","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0305","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0028-3908(02)00217-4","article-title":"Lithium induces brain-derived neurotrophic factor and activates TrkB in rodent cortical neurons: an essential step for neuroprotection against glutamate excitotoxicity","volume":"43","author":"Hashimoto","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0310","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ydbio.2012.05.037","article-title":"A cell-autonomous defect in skeletal muscle satellite cells expressing low levels of survival of motor neuron protein","volume":"368","author":"Hayhurst","year":"2012","journal-title":"Dev Biol"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0315","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1046\/j.1471-4159.2003.01670.x","article-title":"Protein kinase and protein phosphatase expression in amyotrophic lateral sclerosis spinal cord","volume":"85","author":"Hu","year":"2003","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0320","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1101\/gad.1941310","article-title":"Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model","volume":"24","author":"Hua","year":"2010","journal-title":"Genes Dev"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0325","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.mcn.2012.07.002","article-title":"Lithium reduced neural progenitor apoptosis in the hippocampus and ameliorated functional deficits after irradiation to the immature mouse brain","volume":"51","author":"Huo","year":"2012","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0330","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/nrn2755","article-title":"Emerging roles of Wnts in the adult nervous system","volume":"11","author":"Inestrosa","year":"2010","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0335","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1007\/s11481-012-9417-5","article-title":"Wnt signaling: role in Alzheimer disease and schizophrenia","volume":"7","author":"Inestrosa","year":"2012","journal-title":"J Neuroimmune Pharmacol"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0340","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/hmg\/9.3.341","article-title":"Reduced survival motor neuron (Smn) gene dose in mice leads to motor neuron degeneration: an animal model for spinal muscular atrophy type III","volume":"9","author":"Jablonka","year":"2000","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0345","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1093\/hmg\/ddn156","article-title":"Reduced SMN protein impairs maturation of the neuromuscular junctions in mouse models of spinal muscular atrophy","volume":"17","author":"Kariya","year":"2008","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0350","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1212\/WNL.59.4.609","article-title":"Pilot trial of albuterol in spinal muscular atrophy","volume":"59","author":"Kinali","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0355","doi-asserted-by":"crossref","first-page":"8455","DOI":"10.1073\/pnas.93.16.8455","article-title":"A molecular mechanism for the effect of lithium on development","volume":"93","author":"Klein","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0360","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.expneurol.2007.03.004","article-title":"Inhibition of glycogen synthase kinase-3 suppresses the onset of symptoms and disease progression of G93A-SOD1 mouse model of ALS","volume":"205","author":"Koh","year":"2007","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0365","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1460-9568.2005.04191.x","article-title":"Role of GSK-3\u03b2 activity in motor neuronal cell death induced by G93A or A4V mutant hSOD1 gene","volume":"22","author":"Koh","year":"2005","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0370","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1523\/JNEUROSCI.4434-08.2009","article-title":"Impaired synaptic vesicle release and immaturity of neuromuscular junctions in spinal muscular atrophy mice","volume":"29","author":"Kong","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0375","doi-asserted-by":"crossref","first-page":"e46353","DOI":"10.1371\/journal.pone.0046353","article-title":"Limited phenotypic effects of selectively augmenting the SMN protein in the neurons of a mouse model of severe spinal muscular atrophy","volume":"7","author":"Lee","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0380","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.ydbio.2011.05.667","article-title":"Muscles in a mouse model of spinal muscular atrophy show profound defects in neuromuscular development even in the absence of failure in neuromuscular transmission or loss of motor neurons","volume":"356","author":"Lee","year":"2011","journal-title":"Dev Biol"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0385","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","article-title":"Identification and characterization of a spinal muscular atrophy-determining gene","volume":"80","author":"Lefebvre","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0390","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/ng0797-265","article-title":"Correlation between severity and SMN protein level in spinal muscular atrophy","volume":"16","author":"Lefebvre","year":"1997","journal-title":"Nat Genet"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0395","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1093\/hmg\/ddg143","article-title":"Therapeutic benefits of cardiotrophin-1 gene transfer in a mouse model of spinal muscular atrophy","volume":"12","author":"Lesbordes","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0400","doi-asserted-by":"crossref","first-page":"e15457","DOI":"10.1371\/journal.pone.0015457","article-title":"Synaptic defects in the spinal and neuromuscular circuitry in a mouse model of spinal muscular atrophy","volume":"5","author":"Ling","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0405","doi-asserted-by":"crossref","first-page":"R111","DOI":"10.1093\/hmg\/ddq147","article-title":"Spinal muscular atrophy: mechanisms and therapeutic strategies","volume":"19","author":"Lorson","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0410","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/emboj\/20.1.27","article-title":"Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3\u03b2 conditional transgenic mice","volume":"20","author":"Lucas","year":"2001","journal-title":"EMBO J"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0415","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1016\/S0140-6736(08)60921-6","article-title":"Spinal muscular atrophy","volume":"371","author":"Lunn","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0420","first-page":"41","article-title":"Lithium-mediated protection against ethanol neurotoxicity","volume":"4","author":"Luo","year":"2010","journal-title":"Front Neurosci"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0425","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1172\/JCI57291","article-title":"Postsymptomatic restoration of SMN rescues the disease phenotype in a mouse model of severe spinal muscular atrophy","volume":"121","author":"Lutz","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0430","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/00125817-200201000-00004","article-title":"Molecular analysis of spinal muscular atrophy and modification of the phenotype by SMN2","volume":"4","author":"Mailman","year":"2002","journal-title":"Genet Med"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0435","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/nchembio.595","article-title":"A screen for regulators of survival of motor neuron protein levels","volume":"7","author":"Makhortova","year":"2011","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0730","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0006-3223(99)00165-1","article-title":"Lithium at 50: Have the neuroprotective effects of this unique cation been overlooked?","volume":"46","author":"Manji","year":"1999","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0440","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pediatrneurol.2011.09.001","article-title":"Spinal muscular atrophy: a clinical and research update","volume":"46","author":"Markowitz","year":"2012","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0445","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.1093\/hmg\/ddp333","article-title":"Delivery of a read-through inducing compound, TC007, lessens the severity of a spinal muscular atrophy animal model","volume":"18","author":"Mattis","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0450","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.neuron.2010.12.032","article-title":"Early functional impairment of sensory-motor connectivity in a mouse model of spinal muscular atrophy","volume":"69","author":"Mentis","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0455","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1177\/08830738030180080501","article-title":"Role of gabapentin in spinal muscular atrophy: results of a multicenter, randomized Italian study","volume":"18","author":"Merlini","year":"2003","journal-title":"J Child Neurol"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0460","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0022-510X(01)00632-3","article-title":"A placebo-controlled trial of gabapentin in spinal muscular atrophy","volume":"191","author":"Miller","year":"2001","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0465","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1212\/WNL.0b013e31822dc7a5","article-title":"Phase II screening trial of lithium carbonate in amyotrophic lateral sclerosis: examining a more efficient trial design","volume":"77","author":"Miller","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0470","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.neuron.2005.12.001","article-title":"Spinal muscular atrophy: a deficiency in a ubiquitous protein; a motor neuron-specific disease","volume":"48","author":"Monani","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0475","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/hmg\/9.3.333","article-title":"The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn(\u2212\/\u2212) mice and results in a mouse with spinal muscular atrophy","volume":"9","author":"Monani","year":"2000","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0480","doi-asserted-by":"crossref","first-page":"28586","DOI":"10.1074\/jbc.M103166200","article-title":"Glycogen synthase kinase 3beta regulates GATA4 in cardiac myocytes","volume":"276","author":"Morisco","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0485","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.nbd.2012.08.019","article-title":"Defects in neuromuscular junction remodelling in the Smn2B\/\u2212 mouse model of spinal muscular atrophy","volume":"49","author":"Murray","year":"2013","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0490","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1093\/hmg\/ddm367","article-title":"Selective vulnerability of motor neurons and dissociation of pre- and post-synaptic pathology at the neuromuscular junction in mouse models of spinal muscular atrophy","volume":"17","author":"Murray","year":"2008","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0495","doi-asserted-by":"crossref","first-page":"4334","DOI":"10.1093\/hmg\/ddr360","article-title":"Reversible molecular pathology of skeletal muscle in spinal muscular atrophy","volume":"20","author":"Mutsaers","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0500","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/ana.21449","article-title":"Sustained improvement of spinal muscular atrophy mice treated with trichostatin A plus nutrition","volume":"64","author":"Narver","year":"2008","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0505","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1083\/jcb.200210117","article-title":"Intact satellite cells lead to remarkable protection against Smn gene defect in differentiated skeletal muscle","volume":"161","author":"Nicole","year":"2003","journal-title":"J Cell Biol"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0510","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.expneurol.2011.01.017","article-title":"Beta-lactam antibiotic offers neuroprotection in a spinal muscular atrophy model by multiple mechanisms","volume":"229","author":"Nizzardo","year":"2011","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0515","doi-asserted-by":"crossref","first-page":"6990","DOI":"10.1073\/pnas.0500466102","article-title":"Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo","volume":"102","author":"Noble","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0520","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1097\/00001756-199806220-00031","article-title":"Neuroprotective effects of chronic lithium on focal cerebral ischemia in rats","volume":"9","author":"Nonaka","year":"1998","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0525","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1073\/pnas.95.5.2642","article-title":"Chronic lithium treatment robustly protects neurons in the central nervous system against excitotoxicity by inhibiting N-methyl-d-aspartate receptor-mediated calcium influx","volume":"95","author":"Nonaka","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0530","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0022-3565(24)37615-3","article-title":"Lithium protects rat cerebellar granule cells against apoptosis induced by anticonvulsants, phenytoin and carbamazepine","volume":"286","author":"Nonaka","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0535","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1126\/science.1155085","article-title":"Plastin 3 is a protective modifier of autosomal recessive spinal muscular atrophy","volume":"320","author":"Oprea","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0540","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.nmd.2008.05.004","article-title":"Daily salbutamol in young patients with SMA type II","volume":"18","author":"Pane","year":"2008","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0545","doi-asserted-by":"crossref","first-page":"12005","DOI":"10.1523\/JNEUROSCI.2208-10.2010","article-title":"Reduced survival of motor neuron (SMN) protein in motor neuronal progenitors functions cell autonomously to cause spinal muscular atrophy in model mice expressing the human centromeric (SMN2) gene","volume":"30","author":"Park","year":"2010","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0550","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1172\/JCI41615","article-title":"CNS-targeted gene therapy improves survival and motor function in a mouse model of spinal muscular atrophy","volume":"120","author":"Passini","year":"2010","journal-title":"Clin Invest"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0555","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.molmed.2011.01.002","article-title":"Prospects for the gene therapy of spinal muscular atrophy","volume":"17","author":"Passini","year":"2011","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0560","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0092-8674(00)81632-3","article-title":"A novel function for SMN, the spinal muscular atrophy disease gene product, in pre-mRNA splicing","volume":"95","author":"Pellizzoni","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0565","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/17482960902803440","article-title":"Treatment with lithium carbonate does not improve disease progression in two different strains of SOD1 mutant mice","volume":"10","author":"Pizzasegola","year":"2009","journal-title":"Amyotroph Lateral Scler"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0570","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.4155\/fmc.10.228","article-title":"Drug discovery and development for spinal muscular atrophy: lessons from screening approaches and future challenges for clinical development","volume":"2","author":"Pruss","year":"2010","journal-title":"Future Med Chem"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0575","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1083\/jcb.200610053","article-title":"A Drosophila melanogaster model of spinal muscular atrophy reveals a function for SMN in striated muscle","volume":"176","author":"Rajendra","year":"2007","journal-title":"J Cell Biol"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0580","doi-asserted-by":"crossref","first-page":"6210","DOI":"10.1073\/pnas.0937423100","article-title":"Postinsult treatment with lithium reduces brain damage and facilitates neurological recovery in a rat ischemia\/reperfusion model","volume":"100","author":"Ren","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0585","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1093\/hmg\/ddq023","article-title":"SAHA ameliorates the SMA phenotype in two mouse models for spinal muscular atrophy","volume":"19","author":"Riessland","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0590","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1083\/jcb.201207087","article-title":"Antisense-based therapy for the treatment of spinal muscular atrophy","volume":"199","author":"Rigo","year":"2012","journal-title":"J Cell Biol"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0595","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1093\/hmg\/ddn426","article-title":"Delivery of recombinant follistatin lessens disease severity in a mouse model of spinal muscular atrophy","volume":"18","author":"Rose","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0600","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1128\/MCB.06077-11","article-title":"A role for SMN exon 7 splicing in the selective vulnerability of motor neurons in spinal muscular atrophy","volume":"32","author":"Ruggiu","year":"2012","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0605","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1523\/JNEUROSCI.4496-09.2010","article-title":"Altered intracellular Ca2+ homeostasis in nerve terminals of severe spinal muscular atrophy mice","volume":"30","author":"Ruiz","year":"2010","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0615","article-title":"Severe SMA mice show organ impairment that cannot be rescued by therapy with the HDACi JNJ-26481585","author":"Schreml","year":"2012","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0620","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1089\/hum.2010.114","article-title":"Combination of SMN trans-splicing and a neurotrophic factor increases the life span and body mass in a severe model of spinal muscular atrophy","volume":"22","author":"Shababi","year":"2011","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0625","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1124\/mol.106.030676","article-title":"Concurrent administration of Neu 2000 and lithium produces marked improvement of motor neuron survival, motor function, and mortality in a mouse model of amyotrophic lateral sclerosis","volume":"71","author":"Shin","year":"2007","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0630","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/hmg\/ddp562","article-title":"Ciliary neurotrophic factor-induced sprouting preserves motor function in a mouse model of mild spinal muscular atrophy","volume":"19","author":"Simon","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0635","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1021\/cb800120t","article-title":"DcpS as a therapeutic target for spinal muscular atrophy","volume":"3","author":"Singh","year":"2008","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0640","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.nurx.2006.01.010","article-title":"Therapeutics development for spinal muscular atrophy","volume":"3","author":"Sumner","year":"2006","journal-title":"NeuroRx"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0645","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1093\/hmg\/ddp253","article-title":"Inhibition of myostatin does not ameliorate disease features of severe spinal muscular atrophy mice","volume":"18","author":"Sumner","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0650","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0960-8966(96)00018-1","article-title":"DNA fragmentation and BCL-2 expression in infantile spinal muscular atrophy","volume":"6","author":"Tews","year":"1996","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0655","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1021\/jm061475p","article-title":"Synthesis and biological evaluation of novel 2,4-diaminoquinazoline derivatives as SMN2 promoter activators for the potential treatment of spinal muscular atrophy","volume":"51","author":"Thurmond","year":"2008","journal-title":"J Med Chem"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0660","doi-asserted-by":"crossref","first-page":"e26164","DOI":"10.1371\/journal.pone.0026164","article-title":"SMN requirement for synaptic vesicle, active zone and microtubule postnatal organization in motor nerve terminals","volume":"6","author":"Torres-Benito","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0665","doi-asserted-by":"crossref","first-page":"456478","DOI":"10.1155\/2012\/456478","article-title":"Therapy development for spinal muscular atrophy in SMN independent targets","volume":"2012","author":"Tsai","year":"2012","journal-title":"Neural Plast"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0670","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.nbd.2011.06.021","article-title":"IGF-1 delivery to CNS attenuates motor neuron cell death but does not improve motor function in type III SMA mice","volume":"45","author":"Tsai","year":"2012","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0675","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1007\/s00109-008-0388-1","article-title":"Multiple therapeutic effects of valproic acid in spinal muscular atrophy model mice","volume":"86","author":"Tsai","year":"2008","journal-title":"J Mol Med (Berl)"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0680","doi-asserted-by":"crossref","first-page":"35ra42","DOI":"10.1126\/scitranslmed.3000830","article-title":"Systemic delivery of scAAV9 expressing SMN prolongs survival in a model of spinal muscular atrophy","volume":"2","author":"Valori","year":"2010","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0685","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1254\/jphs.CRJ05009X","article-title":"Lithium: potential therapeutics against acute brain injuries and chronic neurodegenerative diseases","volume":"99","author":"Wada","year":"2005","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0690","doi-asserted-by":"crossref","first-page":"7951","DOI":"10.1073\/pnas.122062299","article-title":"Direct, activating interaction between glycogen synthase kinase-3beta and p53 after DNA damage","volume":"99","author":"Watcharasit","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0695","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0306-4522(01)00311-6","article-title":"Lithium suppresses excitotoxicity-induced striatal lesions in a rat model of Huntington\u2019s disease","volume":"106","author":"Wei","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0700","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s00439-006-0156-7","article-title":"Mildly affected patients with spinal muscular atrophy are partially protected by an increased SMN2 copy number","volume":"119","author":"Wirth","year":"2006","journal-title":"Hum Genet"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0705","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1093\/hmg\/ddi131","article-title":"A non-sequence-specific requirement for SMN protein activity: the role of aminoglycosides in inducing elevated SMN protein levels","volume":"14","author":"Wolstencroft","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0710","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1517\/14712598.2010.529895","article-title":"Stem cell-erived neurotrophic support for the neuromuscular junction in spinal muscular atrophy","volume":"10","author":"Wyatt","year":"2010","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0715","doi-asserted-by":"crossref","first-page":"4032","DOI":"10.4161\/cc.8.24.10111","article-title":"Regulation of protein stability by GSK3 mediated phosphorylation","volume":"8","author":"Xu","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0720","doi-asserted-by":"crossref","first-page":"519","DOI":"10.2131\/jts.34.519","article-title":"Severe toxicity and cyclooxygenase (COX)-2 mRNA increase by lithium in the neonatal mouse kidney","volume":"34","author":"Yoshioka","year":"2009","journal-title":"J Toxicol Sci"},{"key":"10.1016\/j.neuroscience.2013.07.026_b0725","doi-asserted-by":"crossref","first-page":"33067","DOI":"10.1074\/jbc.M212635200","article-title":"Inhibitory phosphorylation of glycogen synthase kinase-3 (GSK-3) in response to lithium. Evidence for autoregulation of GSK-3","volume":"278","author":"Zhang","year":"2003","journal-title":"J Biol Chem"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452213006088?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452213006088?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T13:19:43Z","timestamp":1746019183000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452213006088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":145,"alternative-id":["S0306452213006088"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2013.07.026","relation":{},"ISSN":["0306-4522"],"issn-type":[{"type":"print","value":"0306-4522"}],"subject":[],"published":{"date-parts":[[2013,10]]}}}